Cardiovascular and Renal Drugs Advisory Committee Roster

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | HHS Home Page

FDA/Center for Drug Evaluation and Research

Applying for Membership on FDA Advisory Committees

As part of the Food and Drug Administration’s (FDA’s) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. More info (Posted 2/27/2007)

Current Number of Vacancies =4

Note, one or more vacancies may be in the nomination process or a final appointment may have been made.

Chair

Designated Federal Officer
Elaine Ferguson, M.S., R.Ph.
Advisors and Consultants Staff HFD-21
Center for Drug Evaluation and Research
Food and Drug Administration
5600 Fishers Lane
Rockville, Maryland 20857
PH 301/827-7001 FAX 301/827-6776
Elaine.Ferguson@fda.hhs.gov

Henry R. Black, M.D.
Expertise: Nephrology, Hypertension
Term: 10/31/2007-6/30/2011
Clinical Professor of Internal Medicine
Department of Internal Medicine
New York University School of Medicine
550 First Avenue
New York, New York 10016

* Steven D. Findlay, M.P.H.
Expertise: Health Policy Analyst
Term: 1/16/2006 - 6/30/2009
Consumers Union
1101 17th St, NW
Suite 500
Washington, District of Columbia 20036

John M. Flack, M.D., M.P.H.
Expertise: Hypertension/Internal Medicine
Term: 1/16/2006 - 6/30/2009
Department of Medicine
University Health Center
Wayne State University
4201 St. Antoine, Suite 2E
Detroit, Michigan 48201

**Jonathan C Fox, M.D., Ph.D., F.A.C.C.
Expertise: Industry Representative
Term: 6/23/08-10/31/11
Vice President, Clinical Therapeutic Area
Cardiovascular and Gastrointestinal Diseases
AstraZeneca LP
Wilmington, Delaware 19850-5437

Robert A. Harrington, M.D., F.A.C.C.
Expertise: Interventional Cardiology/ Cardiovascular Medicine
Term: 1/16/2006 - 6/30/2009
Professor of Medicine
Division of Cardiology,
Department of Medicine
Duke University Medical School
Duke Clinical Research Institute
2400 Pratt Street, NP 7007
Room 0311, Terrace Level
Durham, North Carolina 27705

Abraham Michael Lincoff, M.D., F.A.C.C.
Expertise: Interventional Cardiology/ Cardiovascular Medicine
Term: 1/16/2006 - 6/30/2009
Professor of Medicine
Department of Cardiovascular Medicine
The Cleveland Clinic Foundation
Desk F25, 9500 Euclid Avenue
Cleveland, Ohio 44195

James D. Neaton, Ph.D.
Expertise: Biostatistics
Term: 10/31/2007-6/30/2011
Professor of Biostatistics
Division of Biostatistics
Coordinating Centers for Biometric Research
University of Minnesota School of Public Health
2221 University Avenue S.E., Suite 200
Minneapolis, Minnesota 55414

Emil P. Paganini, M.D., F.A.C.P., F.R.C.P.
Expertise: Adult Nephrology
Term: 1/4/2007 - 6/30/2010
Critical Care Nephrology Consulting
10427 Mayfield Road
Chesterland, Ohio 44026

*Consumer Representative
** Industry Representative (non voting)

PDF requires the free Adobe Acrobat Reader

Back to Top
Back to Cardiovascular and Renal Drugs Advisory Committee Info
Human Drug Advisory Committee Information

Updated: July 14, 2008